AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Price to Book Value: 0.4567 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 0.4567 |
| November 21, 2024 | 0.4192 |
| November 20, 2024 | 0.443 |
| November 19, 2024 | 0.3613 |
| November 18, 2024 | 0.3408 |
| November 15, 2024 | 0.3408 |
| November 14, 2024 | 0.3408 |
| November 13, 2024 | 0.3442 |
| November 12, 2024 | 0.3613 |
| November 11, 2024 | 0.3715 |
| November 08, 2024 | 0.3749 |
| November 07, 2024 | 0.3749 |
| November 06, 2024 | 0.3749 |
| November 05, 2024 | 0.3713 |
| November 04, 2024 | 0.3679 |
| November 01, 2024 | 0.3679 |
| October 31, 2024 | 0.3679 |
| October 30, 2024 | 0.3713 |
| October 29, 2024 | 0.3782 |
| October 28, 2024 | 0.3748 |
| October 25, 2024 | 0.3645 |
| October 24, 2024 | 0.3645 |
| October 23, 2024 | 0.3679 |
| October 22, 2024 | 0.3679 |
| October 21, 2024 | 0.3679 |
| Date | Value |
|---|---|
| October 18, 2024 | 0.3577 |
| October 17, 2024 | 0.3509 |
| October 16, 2024 | 0.3611 |
| October 15, 2024 | 0.3577 |
| October 14, 2024 | 0.3509 |
| October 11, 2024 | 0.3577 |
| October 10, 2024 | 0.3543 |
| October 09, 2024 | 0.3543 |
| October 08, 2024 | 0.3543 |
| October 07, 2024 | 0.3543 |
| October 04, 2024 | 0.3645 |
| October 03, 2024 | 0.3543 |
| October 02, 2024 | 0.3577 |
| October 01, 2024 | 0.3577 |
| September 30, 2024 | 0.3645 |
| September 27, 2024 | 0.3216 |
| September 26, 2024 | 0.3201 |
| September 25, 2024 | 0.3186 |
| September 24, 2024 | 0.3156 |
| September 23, 2024 | 0.3156 |
| September 20, 2024 | 0.3186 |
| September 19, 2024 | 0.3277 |
| September 18, 2024 | 0.3216 |
| September 17, 2024 | 0.3216 |
| September 16, 2024 | 0.3186 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2974
Minimum
Aug 16 2024
5.443
Maximum
Sep 29 2023
2.030
Average
1.900
Median
Jun 27 2023
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.262 |
| Arbutus Biopharma Corp | 6.222 |
| GlycoMimetics Inc | 1.796 |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 1.243 |
Price to Book Value Related Metrics
| Price | 1.34 |
| Earnings Yield | -152.2% |
| Market Cap | 40.04M |